DAM
UTHR icon

Delta Asset Management’s United Therapeutics UTHR Stock Holding History

Delta Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-50
Closed -$6K – 690
2018
Q2 		$6K Hold
50
– – ﹤0.01% 519
2018
Q1 		$6K Hold
50
– – ﹤0.01% 515
2017
Q4 		$7K Hold
50
– – ﹤0.01% 486
2017
Q3 		$6K Hold
50
– – ﹤0.01% 474
2017
Q2 		$6K Hold
50
– – ﹤0.01% 474
2017
Q1 		$7K Hold
50
– – ﹤0.01% 473
2016
Q4 		$7K Hold
50
– – ﹤0.01% 466
2016
Q3 		$6K Hold
50
– – ﹤0.01% 477
2016
Q2 		$5K Hold
50
– – ﹤0.01% 493
2016
Q1 		$6K Buy
+50
New +$6.33K ﹤0.01% 462

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Delta Asset Management's UTHR Position: Q3 2018 in Review

Delta Asset Management sold out of United Therapeutics (UTHR) in Q3 2018, closing a stake of 50 shares — an estimated $6K sold.

Delta Asset Management first reported a position in UTHR in Q1 2016 and held it in 10 quarters. The position peaked at $7K in Q4 2017. 367 funds tracked by Wall St. Rank hold UTHR as of Q3 2018.

  • Delta Asset Management reported no remaining United Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Delta Asset Management sold 50 United Therapeutics shares in Q3 2018, an estimated $6K.
  • Delta Asset Management first reported a position in United Therapeutics in Q1 2016 and held it in 10 quarters.
  • Delta Asset Management's United Therapeutics position peaked at $7K in Q4 2017.
  • 367 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2018.

Based on Delta Asset Management's 13F filing for Q3 2018, filed 22 Oct 2018.